Active Clinical Trials

Birth Control Pill Study CF111/303

This study is researching an investigational birth control pill. "Investigational" means that it is still being studied and has not been approved by the US FDA. This investigational pill does not contain estrogen and is being developed to reduce the risk of side effects associated with estrogen including venous thromboembolism.

 The pill being tested in this study will be used for 13 menstrual cycles, approximately 1 year. We are trying to find out if this pill is likely to prevent pregnancy, is safe to use, and whether it causes any side effects. Women in this study should not use other methods of birth control during the study. Participation in this study requires 8 visits with bloodwork and physical exams. 

Qualified participants:
•    healthy, premenopausal women
•    have regular menstrual periods
•    not seeking pregnancy
•    have a regular male sexual partner

Qualified participants will receive:
•    study-related medical exams
•    compensation for time and travel ($50-$150 per completed visit, a maximum of $775)

To view the informed consent document for this study, click here.

If you are interested in seeing if you qualify for this study, fill out the prescreening questionnaire here.

Principal Investigator:
Dr. Kurt Barnhart, MD, MSCE

Sponsor:
Laboratorios Leon Farma S.A.

Research Coordinators:
Arden McAllister
215-615-4205
arden.mcallister@uphs.upenn.edu

clinicaltrials.gov listing

Clinical Trials Now Recruiting!

Active Clinical Trials

Fertility and the BRCA gene

Studies on the Epigenetic Regulation of Human Pregnancy in  Fertile and Infertile Couples and Placental Parameters Sub-Study

Infertility

Paid research study seeking healthy women who are not at risk for pregnancy

Infertility study

Comparative Effectiveness of Pregnancy Failure Management Regimes